Blood-based Early Detection Tests for Gastric Cancer Program, Pilot Clinical Study (Phase I)
Not Applicable
- Conditions
- Gastric Cancer
- Registration Number
- JPRN-UMIN000002209
- Lead Sponsor
- Alere San Diego Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 250
Inclusion Criteria
Not provided
Exclusion Criteria
Subject was taking experimental drug or anticancer drug within the past 30 days. Subject has been confirmed as having cancer in the past. Subject was confirmed as having cancer excluding gastric cancer at present. Major trauma or surgery within the past 3 months before study procedure. Subject is considered by the investigator to be an unsuitable candidate for this study. Known or suspected infection with human immunodeficiency virus or infectious hepatitis.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sensitivity and specificity of biomarhkers
- Secondary Outcome Measures
Name Time Method